The Ministry of Health and Welfare responded to the NA’s inquiry on the ministry's policy operation plan to realize generic drug prices in Korea, explaining that the MOHW is promoting a plan to reduce and adjust drug prices through ‘external reference pricing re-evaluations.’

This means that the ministry will start the external reference pricing reevaluations, which it has continuously discussed with the pharmaceutical industry.

In other words, the ministry has no plans to reduce the price of generic drugs unilaterally and is only considering reviewing the need to reduce or adjust their price by comparing the domestic drug prices with overseas drug prices.

On the 15th,